Gold nanoparticle-based 2′-O-methyl modified DNA probes for breast cancerous theranostics
Abstract
No abstract availableKeywords
Funding Information
- Key project of the National Natural Science Foundation of China (21735002)
- Foundation for Innovative Research Groups of NSFC (21521063)
- National Natural Science Foundation of Hunan Province (2017JJ2039)
This publication has 44 references indexed in Scilit:
- Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast CancerMolecular Pharmaceutics, 2017
- Application of Raman Spectroscopy and Infrared Spectroscopy in the Identification of Breast CancerApplied Spectroscopy, 2016
- Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain RadiotherapyClinical Cancer Research, 2015
- Chitosan-Based Thermoreversible Hydrogel as an in Vitro Tumor Microenvironment for Testing Breast Cancer TherapiesMolecular Pharmaceutics, 2014
- Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controlsProceedings of the National Academy of Sciences, 2013
- Pharmacokinetics and pharmacogenomics in breast cancer chemotherapyAdvanced Drug Delivery Reviews, 2009
- Effect of RNAi-mediated gene silencing of Livin on apoptosis of human breast cancer cell line ZR-75-30Chinese Journal of Cancer Research, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- Side Effects of Adjuvant Treatment of Breast CancerNew England Journal of Medicine, 2001
- TREATMENT OF EARLY CANCER OF THE BREAST: HISTOLOGICAL STAGING AND ROLE OF RADIOTHERAPYThe Lancet, 1976